Global S&T Development Trend Analysis Platform of Resources and Environment
DOI | 10.1126/science.aah4199 |
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance | |
Ku, Sheng Yu1; Rosario, Spencer1,11; Wang, Yanqing1,5; Mu, Ping2; Seshadri, Mukund1,7,8; Goodrich, Zachary W.1,4; Goodrich, Maxwell M.1,5; Labbe, David P.3,4,6,7,11; Gomez, Eduardo Cortes8,9; Wang, Jianmin4,8,9; Long, Henry W.; Xu, Bo6,11; Brown, Myles; Loda, Massimo7,10,11; Sawyers, Charles L.; Ellis, Leigh1; Goodrich, David W.1 | |
2017-01-06 | |
发表期刊 | SCIENCE |
ISSN | 0036-8075 |
EISSN | 1095-9203 |
出版年 | 2017 |
卷号 | 355期号:6320页码:78-83 |
文章类型 | Article |
语种 | 英语 |
国家 | USA; England |
英文摘要 | Prostate cancer relapsing from antiandrogen therapies can exhibit variant histology with altered lineage marker expression, suggesting that lineage plasticity facilitates therapeutic resistance. The mechanisms underlying prostate cancer lineage plasticity are incompletely understood. Studying mouse models, we demonstrate that Rb1 loss facilitates lineage plasticity and metastasis of prostate adenocarcinoma initiated by Pten mutation. Additional loss of Trp53 causes resistance to antiandrogen therapy. Gene expression profiling indicates that mouse tumors resemble human prostate cancer neuroendocrine variants; both mouse and human tumors exhibit increased expression of epigenetic reprogramming factors such as Ezh2 and Sox2. Clinically relevant Ezh2 inhibitors restore androgen receptor expression and sensitivity to antiandrogen therapy. These findings uncover genetic mutations that enable prostate cancer progression; identify mouse models for studying prostate cancer lineage plasticity; and suggest an epigenetic approach for extending clinical responses to antiandrogen therapy. |
领域 | 地球科学 ; 气候变化 ; 资源环境 |
收录类别 | SCI-E |
WOS记录号 | WOS:000391739900047 |
WOS关键词 | SMALL-CELL CARCINOMA ; MOUSE MODEL ; PTEN ; TUMORIGENESIS ; DEFICIENCY ; EXPRESSION ; GENERATION ; DELETION ; PATHWAY ; EZH2 |
WOS类目 | Multidisciplinary Sciences |
WOS研究方向 | Science & Technology - Other Topics |
URL | 查看原文 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/195163 |
专题 | 地球科学 资源环境科学 气候变化 |
作者单位 | 1.RPCI, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; 2.MSKCC, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; 3.Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; 4.Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; 5.RPCI, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; 6.RPCI, Dept Pathol, Buffalo, NY 14263 USA; 7.Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA; 8.Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; 9.Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; 10.Kings Coll London, Div Canc Studies, London SE1 9RT, England; 11.Howard Hughes Med Inst, Chevy Chase, MD 20815 USA |
推荐引用方式 GB/T 7714 | Ku, Sheng Yu,Rosario, Spencer,Wang, Yanqing,et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance[J]. SCIENCE,2017,355(6320):78-83. |
APA | Ku, Sheng Yu.,Rosario, Spencer.,Wang, Yanqing.,Mu, Ping.,Seshadri, Mukund.,...&Goodrich, David W..(2017).Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.SCIENCE,355(6320),78-83. |
MLA | Ku, Sheng Yu,et al."Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance".SCIENCE 355.6320(2017):78-83. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论